RIPK1 and amyotrophic lateral sclerosis: Twenty-nine ALS patients, who were orally administered primidone at the dosage of 31.25 mg every night, completed follow-up visiting back to our ALS center every month during 3 months for measuring the levels of serum RIPK1 and IL-8 by ELISA.